Guidelines and registries: Secondary prophylaxis after AMI with emphasis on the use of beta-blockers and ACE inhibitors

By Otterstad Jan Erik  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 10-12

Informa Healthcare

Access to resources Recommend Favorite

Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities

By Carugo Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups

By TRENKWALDER PETER  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 27-30

Informa Healthcare

Access to resources Recommend Favorite

Effect of beta-blockers, Ca²⁺ antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia

By Rysler Christine   Stoffel Nadina   Buser Andreas   Gratwohl Alois   Tsakiris Dimitrios A.   Stern Martin  

Platelets, Vol. 21, Iss. 1, 2010-08 ,pp. : 77-83

Informa Healthcare

Access to resources Recommend Favorite

Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: A multicenter, open-labeled, three-armed study

By Koylan Nevres   Acarturk Esmeray   Canberk Aykan   Caglar Nail   Caglar Sali   Erdine Serap   Guneri Sema   Ilerigelen Baris   Kabakci Giray   Onder Remzi   Sagkan Olcay   Buyukozturk Kemalettin  

Blood Pressure, Vol. 14, Iss. 1, 2005-07 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite